Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia

(2018) Anjana Radhakutty et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Canagliflozin and cardiovascular and renal events in type 2 diabetes

(2018) Robert Guthrie   POSTGRADUATE MEDICINE

Glucocorticoid-induced diabetes in patients with metastatic spinal cord compression

(2018) Helga Schultz et al.   Endocrine Connections

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

(2018) Stephen D. Wiviott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucocorticoid-induced hyperglycemia (糖皮质激素诱导的高血糖)

(2013) Antonio Perez et al.   Journal of Diabetes

Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD

(2011) Morton G. Burt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM